BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
4.180
-0.340 (-7.52%)
At close: Mar 20, 2026, 4:00 PM EDT
4.180
0.00 (0.00%)
After-hours: Mar 20, 2026, 4:00 PM EDT
BriaCell Therapeutics Employees
BriaCell Therapeutics had 16 employees as of July 31, 2023. The number of employees increased by 10 or 166.67% compared to the previous year.
Employees
16
Change
10
Growth
166.67%
Revenue / Employee
n/a
Profits / Employee
-$1,852,354
Market Cap
32.73M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jul 31, 2023 | 16 | 10 | 166.67% | 16 | 0 |
| Jul 31, 2021 | 6 | 0 | - | 5 | 1 |
| Aug 1, 2019 | 6 | - | - | 5 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| Jasper Therapeutics | 27 |
| Actinium Pharmaceuticals | 25 |
| PDS Biotechnology | 24 |
| INmune Bio | 22 |
| ABVC BioPharma | 19 |
| NovaBay Pharmaceuticals | 14 |
| Rein Therapeutics | 11 |
BCTX News
- 2 days ago - BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference - GlobeNewsWire
- 10 days ago - BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting - GlobeNewsWire
- 15 days ago - BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting - GlobeNewsWire
- 4 weeks ago - BriaCell (BCTX) Expands Biologic Cancer Treatments Through New Agreement - GuruFocus
- 4 weeks ago - BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License - GlobeNewsWire
- 4 weeks ago - BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer - GlobeNewsWire
- 7 weeks ago - BriaCell Therapeutics (BCTX) Shows Promising Results in Metastatic Breast Cancer Treatment - GuruFocus
- 7 weeks ago - BriaCell Patients' Images Show Regression and Resolution of Metastasized Tumors and Immune Activation - GlobeNewsWire